Search

Displaying results 9211 - 9220 of 10000 in total
  1. Drug

    ABT-072

    go.drugbank.com/drugs/DB15156
    Investigational

    ABT-072 is under investigation in clinical trial NCT00890318 (A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat

  2. Drug

    Iopofosine I-131

    go.drugbank.com/drugs/DB15244
    Investigational

    Iopofosine I-131 (NM-404 I-131) is under investigation in clinical trial NCT01495663 (Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned).

    Synonyms: I-131-CLR1404, iopofosine I 131
  3. Drug

    2X-121

    go.drugbank.com/drugs/DB16063
    Investigational

    2X-121 is under investigation in clinical trial NCT03562832 (Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the

  4. Drug

    BGT-DTDS

    go.drugbank.com/drugs/DB18664
    Experimental

    It is under investigation for the treatment of dopamine transporter deficiency syndrome (DTDS). … BGT-DTDS is an investigational gene therapy comprising an adeno-associated viral vector type 2 (AAV2) encoding the human _SLC6A3_ gene.

  5. Drug

    LYB014

    go.drugbank.com/drugs/DB33993
    Experimental

    LYB014 is a biologic drug. LYB014 is under investigation in clinical trial NCT07831226 (Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-59 Years).

  6. Drug

    ALN-6457

    go.drugbank.com/drugs/DB33986
    Experimental

    ALN-6457 is a biologic drug. ALN-6457 is under investigation in clinical trial NCT07832370 (A Trial of ALN-6457 in Adult Participants With Symptomatic Prion Disease (PrD)).

  7. Drug

    LYB017

    go.drugbank.com/drugs/DB33994
    Experimental

    LYB017 is a biologic drug. LYB017 is under investigation in clinical trial NCT07831226 (Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-59 Years).

  8. Drug

    LYB027

    go.drugbank.com/drugs/DB33995
    Experimental

    LYB027 is a biologic drug. LYB027 is under investigation in clinical trial NCT07831226 (Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-59 Years).

  9. Drug

    SL1CC

    go.drugbank.com/drugs/DB34006
    Experimental

    SL1CC is a biologic drug. SL1CC is under investigation in clinical trial NCT07841002 (CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid Leukemia).

  10. Drug

    Fialuridine

    go.drugbank.com/drugs/DB15427
    Investigational

    Fialuridine is under investigation in clinical trial NCT01337466 (Biodistribution and Dosimetry Evaluation of [124I]FIAU).